Falasiri S - Search Results

1

Reconnaissance of tumor immune microenvironment spatial heterogeneity in metastatic renal cell carcinoma and correlation with immunotherapy response.

Hajiran A, Chakiryan N, Aydin AM, Zemp L, Nguyen J, Laborde JM, Chahoud J, Spiess PE, Zaman S, Falasiri S, Fournier M, Teer JK, Dhillon J, McCarthy S, Moran-Segura C, Katende EN, Sexton WJ, Koomen JM, Mulé J, Kim Y, Manley B. Hajiran A, et al. Among authors: falasiri s. Clin Exp Immunol. 2021 Apr;204(1):96-106. doi: 10.1111/cei.13567. Epub 2021 Feb 9. Clin Exp Immunol. 2021. PMID: 33346915 Free PMC article.

2

Quantification of T- and B-cell Immune Receptor Distribution Diversity Characterizes Immune Cell Infiltration and Lymphocyte Heterogeneity in Clear Cell Renal Cell Carcinoma.

Ferrall-Fairbanks MC, Chakiryan NH, Chobrutskiy BI, Kim Y, Teer JK, Berglund A, Mulé JJ, Fournier M, Siegel EM, Dhillon J, Falasiri SSA, Arturo JF, Katende EN, Blanck G, Manley BJ, Altrock PM. Ferrall-Fairbanks MC, et al. Among authors: falasiri ssa. Cancer Res. 2022 Mar 1;82(5):929-942. doi: 10.1158/0008-5472.CAN-21-1747. Cancer Res. 2022. PMID: 35031572 Free PMC article.

3

Retroperitoneal drop metastases following robotic partial nephrectomy for renal cell carcinoma.

Elgendi K, Nelwan D, Sirard RB 3rd, Falasiri S, Patel T. Elgendi K, et al. Among authors: falasiri s. Urol Case Rep. 2023 Jun 27;50:102478. doi: 10.1016/j.eucr.2023.102478. eCollection 2023 Sep. Urol Case Rep. 2023. PMID: 37455780 Free PMC article.

4

Chemical complementarity between tumor resident, T-cell receptor CDR3s and MAGEA3/6 correlates with increased melanoma survival: Potential relevance to MAGE vaccine auto-reactivity.

Eakins RA, Chobrutskiy A, Teer JK, Patel DN, Hsiang M, Huda TI, Zaman S, Sexton WJ, Coppola D, Falasiri S, Blanck G, Chobrutskiy BI. Eakins RA, et al. Among authors: falasiri s. Mol Immunol. 2022 Oct;150:58-66. doi: 10.1016/j.molimm.2022.08.001. Epub 2022 Aug 17. Mol Immunol. 2022. PMID: 35987136

5

A comparison of immune receptor recombination databases sourced from tumour exome or RNAseq files: Verifications of immunological distinctions between primary and metastatic melanoma.

Patel DN, Yeagley M, Arturo JF, Falasiri S, Chobrutskiy BI, Gozlan EC, Blanck G. Patel DN, et al. Among authors: falasiri s. Int J Immunogenet. 2021 Oct;48(5):409-418. doi: 10.1111/iji.12550. Epub 2021 Jul 23. Int J Immunogenet. 2021. PMID: 34298587

6

Electrostatic Complementarity of T-Cell Receptor-Alpha CDR3 Domains and Mutant Amino Acids Is Associated with Better Survival Rates for Sarcomas.

Yeagley M, Chobrutskiy BI, Gozlan EC, Medikonda N, Patel DN, Falasiri S, Callahan BM, Huda T, Blanck G. Yeagley M, et al. Among authors: falasiri s. Pediatr Hematol Oncol. 2021 Apr;38(3):251-264. doi: 10.1080/08880018.2020.1843576. Epub 2021 Feb 22. Pediatr Hematol Oncol. 2021. PMID: 33616477

7

The Immune Microenvironment in Penile Cancer and Rationale for Immunotherapy.

Ahmed ME, Falasiri S, Hajiran A, Chahoud J, Spiess PE. Ahmed ME, et al. Among authors: falasiri s. J Clin Med. 2020 Oct 17;9(10):3334. doi: 10.3390/jcm9103334. J Clin Med. 2020. PMID: 33080912 Free PMC article. Review.

8

Chemical complementarity between immune receptor CDR3s and IDH1 mutants correlates with increased survival for lower grade glioma.

Chobrutskiy BI, Yeagley M, Tipping P, Zaman S, Diviney A, Patel DN, Falasiri S, Uversky VN, Blanck G. Chobrutskiy BI, et al. Among authors: falasiri s. Oncogene. 2020 Feb;39(8):1773-1783. doi: 10.1038/s41388-019-1101-2. Epub 2019 Nov 18. Oncogene. 2020. PMID: 31740784

9

Electrostatic complementarity of B-cell receptor CDR3s and TP53-mutant amino acids in breast cancer is associated with increased disease-free survival rates.

Arturo JF, Chobrutskiy BI, Yeagley M, Patel DN, Falasiri S, Patel JS, Blanck G. Arturo JF, et al. Among authors: falasiri s. Cell Mol Immunol. 2020 Jul;17(7):776-778. doi: 10.1038/s41423-019-0328-8. Epub 2019 Nov 15. Cell Mol Immunol. 2020. PMID: 31729463 Free PMC article. No abstract available.

10

Germline cytoskeletal and extra-cellular matrix-related single nucleotide variations associated with distinct cancer survival rates.

Falasiri S, Rahman T, Tu YN, Fawcett TJ, Blanck G. Falasiri S, et al. Gene. 2018 Aug 30;669:91-98. doi: 10.1016/j.gene.2018.05.037. Epub 2018 May 17. Gene. 2018. PMID: 29778426

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11 results

Search Page

Filters